Form 4 for CATX Perspective Therapeutics, Inc.
Accepted 2023-12-19 00:00:00 ET · period of report 2023-12-15 · accession 0001437749-23-034931 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-12-19 | 2023-12-15+ | CATX | Puhlmann Markus | Chief Medical Off | P - Purchase | $0.316 | +595.4K | 635.0K | +1,504% | +$188.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-19 | P | A | 400,000 | $0.34 | 1,095,425 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-18 | P | A | 60,419 | $0.26 | 695,425 | D | — | — | |
| 3 | Common | Common Stock | 2023-12-15 | P | A | 135,006 | $0.27 | 635,006 | D | — | — |